Propranolol's Effects on Heart Arrhythmias in Mice with Long QT Syndrome
Author Information
Author(s): Thomas G, Killeen M J, Grace A A, Huang C L-H
Primary Institution: University of Cambridge
Hypothesis
Can propranolol separate early afterdepolarizations from arrhythmogenic substrate in genetically modified mouse hearts modeling human long QT syndrome?
Conclusion
Propranolol can suppress early afterdepolarizations and spontaneous arrhythmias in bradycardic Scn5a+/Δ hearts, but higher concentrations may exacerbate arrhythmogenic substrate.
Supporting Evidence
- Propranolol suppressed early afterdepolarizations and episodes of ventricular tachycardia in Scn5a+/Δ hearts.
- Lower concentrations of propranolol reduced arrhythmogenicity in spontaneously beating hearts.
- Higher concentrations of propranolol increased the incidence of arrhythmias during programmed electrical stimulation.
Takeaway
This study shows that a heart medicine called propranolol can help stop some heart problems in mice, but too much of it can actually make things worse.
Methodology
The study used isolated, Langendorff-perfused murine hearts to compare monophasic action potentials and arrhythmogenic tendencies under different concentrations of propranolol.
Potential Biases
Potential bias in the interpretation of results due to the specific genetic modifications in the mouse model.
Limitations
The study was conducted in a murine model, which may not fully replicate human responses.
Participant Demographics
Genetically modified mice (Scn5a+/Δ) and wild type mice.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website